Abstract
It is well known that the pharmaceutical industry produces enormous amounts of documentation for research, development and commercial purposes, some of it governed by legislation, other parts not. This paper attempts to summarise how one particular company, Glaxo Group Research Ltd., (GGR), meets the legislative requirements with respect to scientific documentation and how it is endeavouring to organise its documentation to meet the current and future needs of its users.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
